Posted by Michael Wonder on 31 Oct 2024
PHARMAC looks to fund a medicine to keep bones strong
31 October 2024 - PHARMAC is consulting on a proposal to widen access to denosumab for more people with osteoporosis and people who have high levels of calcium in their blood and have cancer.
PHARMAC currently funds a denosumab 60 mg injection (Prolia) for people with severe osteoporosis and is looking to widen access to people who can’t use other funded treatments, or if their condition isn’t improving when using these.
